Navigation Links
Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
Date:6/30/2009

NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appointed to the Company's Board of Directors. Rib-X's board now consists of eleven members.

"We are extremely pleased that Russell Greig has joined the Rib-X Board of Directors," said Dr. Susan Froshauer, President and Chief Executive Officer, Rib-X. "Russell brings an impressive mix of both R&D and business development experience that will be crucial as the Company grows and continues to move products through the development pipeline."

Russell Greig is President of SR One, the venture capital arm of GlaxoSmithKline (GSK). Prior to joining SR One, he served as President of GSK's Pharmaceuticals International from 2003 to 2008, and also served on the GSK Corporate Executive Team. Dr. Greig originally joined GSK (then SmithKline & French) in 1980 in the Departments of Tumor and Cell Biology. In 1991, following the merger with Beecham, he was appointed Vice President, Project Management. From 1993 to 1996, he served as Vice President and Director of Advanced Technologies in Genetics with special responsibility for managing collaborations with The Institute of Genomic Research and Human Genome Sciences. In 1996 Dr. Greig joined SmithKline Beecham's European Pharmaceutical Operations as Vice President and Director of European Market Development, and was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline Beecham with Glaxo Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development.

Dr. Greig also serves on the boards of Genocea Biosciences and the Edinburgh BioQuarter Commerci
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
2. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
3. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
6. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
7. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
9. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
11. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... Mapp Biopharmaceutical,s valiant effort to produce ... fight the Ebola outbreak will make the public ... of pharmaceuticals can be, according to Kalorama Information.  ... some may be taken aback by the three-month ... knowledge are well aware of the complex issues ...
(Date:10/20/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced four new ... and provides a good start to Q4.  The orders are for ... and one in the Middle East . ... Peter Bruijns , President & CEO. "Total bidding activity and ... have been for any complete year since the company has tracked ...
(Date:10/20/2014)... Oct. 20, 2014 PureTech , a ... big healthcare problems, announced today the closing of ... participation from Invesco Perpetual, a $120 Billion group ... drive PureTech,s existing pipeline forward and to advance ... the scientific creativity to really go for the ...
(Date:10/20/2014)... Local veterinary surgeon, Dr. Tim McCarthy is ... donor stem cells for dogs with osteoarthritis. Dr. McCarthy ... performed clinical stem cell therapy for 7 years. The ... a single injection of donor stem cells into one ... and inflammation in the treated joints. , Candidates ...
Breaking Biology Technology:Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 2Kalorama: ZMapp Highlights Need For Faster Biopharmaceutical Production 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6Cascade Veterinary Referral Center Seeks Candidates for an Investigational Study of Stem Cells for Dogs with Arthritis 2
... Informex , the leading meeting place for buyers and sellers ... in the Informex Online Series, titled Beyond Manufacturing: Driving the ... international presence for the event. On December 1, 2011 at ... virtual platform that can be accessed from anywhere in the ...
...  If algae is to be the solution for America,s pain ... that a reality. Applications are now available for continuing education ... workers as general science technicians in the rapidly expanding biofuels ... Approximately 55 students will begin classes in March ...
... streaming of real-time information across your field of vision is ... prototype contact lens that could potentially provide the wearer with ... 22 November, in IOP Publishing,s Journal of Micromechanics and ... its safety by testing it on live eyes. There were ...
Cached Biology Technology:International Attendance for Networking and Education at Informex Beyond Manufacturing 2International Attendance for Networking and Education at Informex Beyond Manufacturing 3Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry 2Free Job Training: 55 Grants Available to Retrain Workers for Biofuels Industry 3Terminator-style info-vision takes step towards reality 2
(Date:10/18/2014)... of patients with undiagnosed, suspected genetic conditions, a certain ... higher molecular diagnostic yield than traditional molecular diagnostic methods, ... The study is being released to coincide with the ... sequencing, which sequences the protein­coding region of the genome ... in a cell or organism), has been rapidly applied ...
(Date:10/17/2014)... shown for the first time how bacteria can grow ... them the opportunity to get tremendous insights into bacteria ... also discovered the bacterial growth in chronic lung infections ... down by the immune cells. The researchers discovered the ... the bacteria, forcing the bacteria to switch to a ...
(Date:10/16/2014)... of Marine Science have received a 3-year, $392,773 ... the streams and wetlands most vulnerable to sea-level ... governments and citizens conserve these important ecosystems. , ... tidal-marsh observations first gathered by VIMS scientists in ... today,s researchers accurately map the slow but inexorable ...
Breaking Biology News(10 mins):Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3Scientists opens black box on bacterial growth in cystic fibrosis lung infection 2EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3
... us from heart disease and cancer, a balanced diet and ... mental disorders. "Food is like a ... UCLA professor of neurosurgery and physiological science who has spent ... the brain. "Diet, exercise and sleep have the potential to ...
... out more soot for the amount of fuel used than ... twice as much soot as previously estimated, according to the ... NOAA and the University of Colorado conducted the study and ... journal Geophysical Research Letters . The primary ...
... Earlier this month, ThomsonReuters released the 2007 Journal ... most important scholarly journals. The scientific journal Genome ... reported with an impact factor of 11.224, a considerable gain ... measure of a journal,s significance in an academic field. ...
Cached Biology News:Scientists learn how food affects the brain 2Scientists learn how food affects the brain 3Scientists learn how food affects the brain 4Scientists learn how food affects the brain 5NOAA takes first broad look at soot from ships 2
Dako Target Retrieval Solution, Citrate pH 6 (x 10) For more information, please visit Dako' web-site. EU regulatory status: CE US regulatory status: IVD...
... solid. Increases the expression of glutathione peroxidase. ... 2 O. Unstable in aqueous solutions; reconstitute ... 3211-76-5, M.W. 196.1. References: Merck Index ... A.F. 1995. Biochem. J. 306, ...
Mouse monoclonal antibody to QDPR - quinoid dihydropteridine reductase...
Anti-Conjugated Quinaldic Acid...
Biology Products: